Your browser doesn't support javascript.
loading
Activity of venetoclax-based therapy in chronic myelomonocytic leukemia.
Montalban-Bravo, Guillermo; Hammond, Danielle; DiNardo, Courtney D; Konopleva, Marina; Borthakur, Gautam; Short, Nicholas J; Ramos-Perez, Jorge; Guerra, Veronica; Kanagal-Shamanna, Rashmi; Naqvi, Kiran; Sasaki, Koji; Jabbour, Elias; Pemmaraju, Naveen; Kadia, Tapan M; Ravandi, Farhad; Daver, Naval; Estrov, Zeev; Pierce, Sherry; Kantarjian, Hagop; Garcia-Manero, Guillermo.
Afiliação
  • Montalban-Bravo G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. gmontalban1@mdanderson.org.
  • Hammond D; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • DiNardo CD; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Konopleva M; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Borthakur G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Short NJ; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ramos-Perez J; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Guerra V; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kanagal-Shamanna R; Departments of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Naqvi K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Sasaki K; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Jabbour E; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pemmaraju N; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kadia TM; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Ravandi F; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Daver N; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Estrov Z; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Pierce S; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Kantarjian H; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
  • Garcia-Manero G; Departments of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Leukemia ; 35(5): 1494-1499, 2021 05.
Article em En | MEDLINE | ID: mdl-33846541
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Mielomonocítica Crônica / Compostos Bicíclicos Heterocíclicos com Pontes / Antineoplásicos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Sulfonamidas / Leucemia Mielomonocítica Crônica / Compostos Bicíclicos Heterocíclicos com Pontes / Antineoplásicos Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article